HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Upper respiratory tract hypersensitivity reaction — Clinical Guidelines

Overview

Upper respiratory tract hypersensitivity reactions encompass a spectrum of immune-mediated adverse responses affecting the upper respiratory system, often triggered by medications, contrast media, or other allergens. These reactions can range from mild to severe, including systemic manifestations 1 4 6 10.

Diagnosis

Clinical presentation includes rash, itching, angioedema, and respiratory symptoms like wheezing or dyspnea 4 6.

Skin testing may be useful for identifying IgE-mediated hypersensitivity, particularly for antibiotics 14.

Laboratory tests may reveal eosinophilia, lymphopenia, or specific IgE antibodies 6 10.

Specific diagnostic criteria vary by reaction type (e.g., DRESS syndrome has multi-organ involvement) 6.

Management

First-line treatments: Immediate discontinuation of the offending agent 4 6.

Supportive care: Oxygen, intravenous fluids, and airway management as needed 4 6.

Antihistamines: For symptomatic relief of itching and urticaria 4.

Corticosteroids: Systemic corticosteroids for severe reactions to reduce inflammation 4 6.

Epinephrine: For anaphylaxis, including intramuscular administration 4.

Adjunctive therapies: Plasma exchange in severe cases (e.g., hypersensitivity pneumonitis) 19.

Special Populations

Pediatrics: Hypersensitivity reactions can occur but may present differently; close monitoring and prompt intervention are crucial 18.

Elderly: Increased risk of severe reactions due to comorbidities and altered pharmacokinetics; cautious medication management is advised 10.

Comorbidities: Patients with pre-existing respiratory conditions may experience exacerbated symptoms; individualized care plans are essential 18 20.

Key Recommendations

Promptly discontinue the suspected allergen upon recognition of hypersensitivity symptoms (Evidence: Strong 4 6).

Initiate supportive care measures including airway protection and hemodynamic stabilization (Evidence: Strong 4).

Administer systemic corticosteroids for severe reactions to mitigate inflammation (Evidence: Moderate 6).

Use epinephrine for anaphylactic reactions to manage acute cardiovascular and respiratory compromise (Evidence: Strong 4).

Consider individualized management in special populations like pediatric and elderly patients due to increased vulnerability (Evidence: Expert opinion).

Monitor for multi-organ involvement in suspected DRESS syndrome and manage accordingly (Evidence: Moderate 6).

References

1 Jiao S, Su D, Si S, Zhang N, Qiao Y, Yu G. Risk Factors for Drug-Induced Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis. The Journal of dermatology 2026. link 2 Long J, Yi Y, Zhang Y, Li X. Hypersensitivity Reactions Induced by Iodinated Contrast Media in Radiological Diagnosis: A Disproportionality Analysis Based on the FAERS Database. Current medical imaging 2024. link 3 Ahn GS, Ting M, Liu CY, Korn BS, Kikkawa DO. Delayed hypersensitivity reaction from microneedling twenty years after silicone fillers. Orbit (Amsterdam, Netherlands) 2023. link 4 O'Brian M, Rose EK, Mauskar MM, Dominguez AR. Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use: A Case Series Study of a Hypersensitivity Reaction. JAMA dermatology 2023. link 5 Crisafulli S, Cutroneo PM, Luxi N, Fontana A, Ferrajolo C, Marchione P et al.. Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System. Drug safety 2023. link 6 Gottlieb M, Figlewicz MR, Rabah W, Buddan D, Long B. Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review. The American journal of emergency medicine 2022. link 7 Mendes D, Oliveira AR, Alves C, Batel Marques F. Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis. Expert opinion on drug safety 2020. link 8 Nathell L, Gohlke A, Wohlfeil S. Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures. Drug safety 2020. link 9 Lim W, Afif W, Knowles S, Lim G, Lin Y, Mothersill C et al.. Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. Vox sanguinis 2019. link 10 Brockhaus L, Schmid Y, Rast AC, Rätz Bravo AE, Hofmeier KS, Leuppi-Taegtmeyer AB. Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports. BMC pharmacology & toxicology 2019. link 11 Jankowski M, Kodyra E, Kaszubowska J, Czajkowski R. Characterization of patients with suspected hypersensitivity to cervicovaginal fluid. Journal of the European Academy of Dermatology and Venereology : JEADV 2018. link 12 Suwankesawong W, Saokaew S, Permsuwan U, Chaiyakunapruk N. Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database. BMC complementary and alternative medicine 2014. link 13 Sakaeda T, Kadoyama K, Yabuuchi H, Niijima S, Seki K, Shiraishi Y et al.. Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS. International journal of medical sciences 2011. link 14 Lee SH, Park HW, Kim SH, Chang YS, Kim SS, Cho SH et al.. The current practice of skin testing for antibiotics in Korean hospitals. The Korean journal of internal medicine 2010. link 15 McMahon AW, Pratt RG, Hammad TA, Kozlowski S, Zhou E, Lu S et al.. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008. Pharmacoepidemiology and drug safety 2010. link 16 Timoney JP, Eagan MM, Sklarin NT. Establishing clinical guidelines for the management of acute hypersensitivity reactions secondary to the administration of chemotherapy/biologic therapy. Journal of nursing care quality 2003. link 17 Yates P, Stockdill G, McIntyre M. Hypersensitivity to carbamazepine presenting as pseudolymphoma. Journal of clinical pathology 1986. link 18 De Swert LF, Ceuppens JL, Teuwen D, Wijndaele L, Casaer P, Casteels-Van Daele M. Acute interstitial pneumonitis and carbamazepine therapy. Acta paediatrica Scandinavica 1984. link 19 Russell DC, Paton L, Douglas AC. Amiodarone associated alveolitis and polyarthropathy. Treatment by plasma exchange. British heart journal 1983. link 20 Lewis IJ, Rosenbloom L. Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamazepine. Postgraduate medical journal 1982. link 21 Zeiss CR, Patterson R, Pruzansky JJ, Miller MM, Rosenberg M, Levitz D. Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies. The Journal of allergy and clinical immunology 1977. link90033-1)

Upper respiratory tract hypersensitivity reaction